Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you offer a patient with “good-risk” DCIS and an elevated DCISionRT score APBI or WBI?
Good risk DCIS as per RTOG 9804
Answer from: Radiation Oncologist at Community Practice
Based on the technical suitability, either option is fine.
Sign In
or
Register
to read more
20872
Related Questions
How do you approach the discussion about the potential risks of radiation therapy exposure and the development of secondary malignancies for patients with germline BRCA1/2 mutations?
Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?
How do you advise women to manage wound care for breast brachytherapy needle sites for long term cosmetic outcomes?
How do you treat a patient with early-stage breast cancer s/p lumpectomy and oncoplastic reconstruction with a positive margin, when re-excision is not feasible?
Is ultrahypofractionation appropriate for a B51 candidate receiving breast-only radiation?
What dose of reirradiation would you consider for locally recurrent breast cancer after mastectomy, excised with positive margins?
How do you weigh upfront nodal burden when deciding to omit PMRT in a patient with cN1, ypN0 disease after neoadjuvant chemo, mastectomy and ALND?
Does delay to the time of lumpectomy impact your decision to omit radiation?
Would you consider RNI alone without CW for an isolated nodal recurrence after treatment with mastectomy and SNB for an early-stage breast cancer with no prior RT?
Given the final publication of NSABP B-51, for which patients meeting trial eligibility would you still recommend regional nodal irradiation?